Kayoko Kibata
Hirakata, 5731191, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 26 publications
Afatinib plus bevacizumab combination after osimertinib resistance in advanced EGFR-mutant non-small cell lung cancer: Phase II ABCD-study.
Journal: Lung cancer (Amsterdam, Netherlands)
Published: April 20, 2024
SMARCA4-deficient undifferentiated tumor that responded to chemotherapy in combination with immune checkpoint inhibitors: A case report.
Journal: Thoracic cancer
Published: April 18, 2022
Emergent salvage surgery for massive hemoptysis after proton beam therapy for lung cancer: a case report.
Journal: Surgical case reports
Published: February 15, 2021
Nivolumab treatment of elderly Japanese patients with non-small cell lung cancer: subanalysis of a real-world retrospective observational study (CA209-9CR).
Journal: ESMO open
Published: December 10, 2019
Serum high-mobility group box 1 is correlated with interferon-α and may predict disease activity in patients with systemic lupus erythematosus.
Journal: Lupus
Published: July 14, 2019
Real-world effectiveness and safety of nivolumab in patients with non-small cell lung cancer: A multicenter retrospective observational study in Japan.
Journal: Lung cancer (Amsterdam, Netherlands)
Published: June 28, 2019
The immunomodulatory-drug, lenalidomide, sustains and enhances interferon-α production by human plasmacytoid dendritic cells.
Journal: Journal of blood medicine
Published: February 22, 2019
Statins can suppress DC-mediated Th2 responses through the repression of OX40-ligand and CCL17 expression.
Journal: European journal of immunology
Published: November 02, 2018
Pembrolizumab-induced autoimmune encephalitis in a patient with advanced non-small cell lung cancer: A case report.
Journal: Molecular and clinical oncology
Published: October 19, 2018
Last Updated: 09/26/2026